-->


Back to 2014 Fall Congress Meeting Abstracts


Prospective Evaluation of Urinary Metabolic Indices in Severely Obese Adolescents after Weight Loss Surgery
William R. DeFoor, Jr., MD, MPH1, John Asplin, MD2, Todd Jenkins, PhD, MPH1, Linda Kollar, RN1, Elizabeth Jackson, MD1, Thomas Inge, MD1.
1Cincinnati Children's Hospital, Cincinnati, OH, USA, 2Litholink Corporation, Chicago, IL, USA.

BACKGROUND: Observational studies in obese adults have shown abnormal urinary metabolic indices that predispose to nephrolithiasis. Few studies of this nature have been performed in severely obese adolescents. The purpose of this study was to assess urinary stone risk factors in severely obese adolescents and in those undergoing two types of weight loss surgery.
METHODS: A prospective cross-sectional study was performed to assess urinary metabolic profiles in severely obese adolescents who have either not undergone any gastrointestinal surgery or who have undergone Roux-en-Y gastric bypass (RYGB) or vertical sleeve gastrectomy (VSG). Exclusion criteria included previous urologic surgery or a history of urinary stone disease. A family history of stone disease was elicited. 24-hour urine collections were performed at home and evaluated at a central laboratory. Established normal reference ranges for adults were used in the analysis. A linear regression analysis was performed assessing the relationship of the study group with each of the outcomes.
RESULTS: A total of 55 samples were analyzed from 14 non-operative, 10 RYGB, and 7 VSG patients. Demographic data are presented in Table 1. Median BMI was similar between the RYGB and VSG groups. Median urinary metabolic indices are presented in Table 2. The median 24 hour excretion of oxalate was markedly higher in the RYGB group . Calcium and uric acid indices as well as the median supersaturation (SS) of calcium oxalate, calcium phosphate, and uric acid were similar among all groups.
CONCLUSIONS: In severely obese adolescents after RYGB but not VSG surgery, an elevated excretion of oxalate in the urine may portend an increased risk for kidney stone formation. Larger longitudinal studies are needed to verify these findings and to determine the clinical risk of developing stone disease in these patient populations.
Table 1. Patient Demographics
DemographicNon-operativeRYGBVSG
Patients, N
Male
14
6
10
0
7
1
Female8106
Samples, N251812
Age (years), Median17.918.617.6
Weight (kg), Median13310594
Current BMI (kg/m2), Median
Pre-op BMI (kg/m2), Median
50
N/A
36
52
32
51
Time since surgery (years), MedianN/A1.00.8
Family history of nephrolithiasis622

Table 2. Comparison of urinary metabolic indices
Median valuesNormal RangeNon-operativeRYGB groupVSG groupP-value1
Volume (liters)0.5 - 41.311.490.950.74
pH>5.86.26.26.10.87
Calcium (mg/day)<200124841200.32
SS Calcium oxalate6 - 107.215.025.230.88
Oxalate (mg/day)20 - 403442260.01
SS Calcium phosphate0.5 - 20.820.641.070.61
SS Uric acid0 - 10.750.490.830.76
Uric acid (g/day)<0.750.610.570.400.24
Citrate (mg/day)>4505906466870.94

1 Results of a linear regression analysis between study groups


Back to 2014 Fall Congress Meeting Abstracts
© 2017 The Society for Pediatric Urology. All Rights Reserved.
Read Privacy Policy.